| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/14651858.CD004293.PUB2 |
| P698 | PubMed publication ID | 15495098 |
| P50 | author | Arrigo Schieppati | Q114428691 |
| Giuseppe Remuzzi | Q16561003 | ||
| Javier Zamora | Q37841600 | ||
| Annalisa Perna | Q84349157 | ||
| P2093 | author name string | Giovanni A Giuliano | |
| Norbert Braun | |||
| P2860 | cites work | Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome | Q24248134 |
| Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial | Q33181802 | ||
| Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed | Q34577274 | ||
| NIH conference. Membranous nephropathy | Q35910898 | ||
| Recent developments in the management of membranous nephropathy | Q36179760 | ||
| Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals | Q39440039 | ||
| A review of therapeutic studies of idiopathic membranous glomerulopathy | Q40539681 | ||
| Prognosis of idiopathic membranous nephropathy: a methodologic meta-analysis | Q40903232 | ||
| Use of pentoxifylline in membranous nephropathy | Q43652892 | ||
| Mycophenolate mofetil treatment for primary glomerular diseases | Q43889676 | ||
| Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group | Q44134261 | ||
| Rituximab in idiopathic membranous nephropathy: a one-year prospective study | Q44486211 | ||
| A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. | Q50557738 | ||
| Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network. | Q52423773 | ||
| Controlled trial of cyclophosphamide in idiopathic membranous nephropathy | Q53771727 | ||
| Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. | Q54077444 | ||
| Rituximab for idiopathic membranous nephropathy | Q57703309 | ||
| Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy | Q57704416 | ||
| Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review | Q58868736 | ||
| A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome | Q66897193 | ||
| A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children | Q68049223 | ||
| A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy | Q69481607 | ||
| Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy | Q70327291 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy | Q70847542 | ||
| Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide | Q72087908 | ||
| Treatment of membranous nephropathy: a meta-analysis | Q72199732 | ||
| A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group | Q72318341 | ||
| Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency | Q77111666 | ||
| Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group | Q78019561 | ||
| P921 | main subject | nephrotic syndrome | Q504790 |
| idiopathy | Q594841 | ||
| P577 | publication date | 2004-10-18 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q30525655 | Glomerular disease search filters for Pubmed, Ovid Medline, and Embase: a development and validation study. |
| Q36810470 | Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials |
| Q36662933 | Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial |
| Q24193098 | Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome |
| Q34408113 | Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults |
| Q85278383 | Membranous nephropathy |
| Q33920367 | Membranous nephropathy in children: clinical presentation and therapeutic approach |
| Q59132558 | Redox State of Human Serum Albumin and Inflammatory Biomarkers in Hemodialysis Patients with Secondary Hyperparathyroidism During Oral Calcitriol Supplementation for Vitamin D |
| Q38075787 | Rituximab therapy in nephrotic syndrome: implications for patients' management |
Search more.